Detalles de la búsqueda
1.
Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up.
World J Surg Oncol
; 21(1): 322, 2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37833735
2.
Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma.
BMC Gastroenterol
; 22(1): 77, 2022 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35193513
3.
Role of CCR1/5/7 in hepatocellular carcinoma: a study on prognostic evaluation, molecular subtyping, and association with immune infiltration.
Aging (Albany NY)
; 16(7): 6229-6261, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552222
4.
SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma.
Aging (Albany NY)
; 15(16): 8408-8432, 2023 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37632835
5.
Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response.
Sci Rep
; 13(1): 14519, 2023 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37666920
6.
PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
Pharmgenomics Pers Med
; 16: 337-355, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37091827
7.
RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma.
Int J Gen Med
; 16: 4377-4392, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37789880
8.
Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases.
Front Immunol
; 14: 1325445, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38173715
9.
Clinical Significance and Potential Mechanisms of ATP Binding Cassette Subfamily C Genes in Hepatocellular Carcinoma.
Front Genet
; 13: 805961, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35342392
10.
High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma.
Int J Gen Med
; 15: 609-621, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35058711
11.
CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis.
J Hepatocell Carcinoma
; 8: 1323-1338, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34765572
Resultados
1 -
11
de 11
1
Próxima >
>>